Skip to main content

Page last checked

Blend vial · two peptides, one draw

Peptide blend calculator

Choose a blend or enter the milligrams of each peptide in the vial. Enter the liquid volume and select the syringe scale. Enter one amount to see what comes with it, or two amounts to check whether the vial ratio can provide both.

Blend vialor enter your own amounts below
on the label
mg
on the label
mg
mL put into the vial
mL
Syringe

How much do you want?

Your numbers, not suggestions. Fill in one to see what comes with it. Fill in both to see whether this vial can give both.

mcg
mcg
Draw to
—units

3.33 mg/mL of peptide in total · 16.7 + 16.7 mcg per unit

Nothing to work out yet. Enter how much of at least one peptide you want. The tool will show the draw, and what the other peptide does at that draw.

Arithmetic, not a dose. This works out what a draw from your vial contains. It does not say what amount to use, and it is not medical advice. CJC-1295: Human study dose details. Ipamorelin: Human study dose details.

The link keeps this vial, syringe and both amounts so the same result opens again.

Why the two amounts stay linked

Each draw contains both peptides in the same ratio as the vial. Choosing a volume for the first peptide also sets how much of the second comes with it.

Adding water changes the concentration of both peptides by the same factor. It changes the volume needed for a given amount, but it cannot change their ratio.

One draw can match both requested amounts only when those amounts have the vial’s ratio. If they do not, the calculator shows the separate volumes and what each would contain. It does not choose a compromise between them.

Worked examples for three vial ratios

These examples use the opening amounts from the individual compound calculators to show how a fixed ratio works. The paired amounts are arithmetic examples, not a dosing schedule for the combination. Open the dose details below for each compound’s source context.

CJC-1295 and Ipamorelin — 5 mg plus 5 mg

Fixed at 1 to 1. In 3 mL of water, one U-100 unit carries 16.7 mcg of CJC-1295 and 16.7 mcg of Ipamorelin.

Ask this vial for 200 mcg of CJC-1295 and 300 mcg of Ipamorelin:

Set by CJC-1295, the draw is 12.0 units and it brings 200 mcg of Ipamorelin — less than the 300 asked for.

Set by Ipamorelin instead and the draw is 18.0 units, which brings 300 mcg of CJC-1295.

No draw between them gives both. The vial is short of Ipamorelin for this pair of amounts.

CJC-1295
Human study dose details

Human study: 30 to 60 mcg per kilogram of body weight — the two of four rising single-dose levels the authors singled out as safe and relatively easy for healthy adults aged 21 to 61 to handle, using the version carrying the drug-affinity complex; a single injection raised growth hormone 2- to 10-fold for six days or more and IGF-I 1.5- to 3-fold for nine to eleven days. Route: subcutaneous.

Ipamorelin
Human study dose details

Human study: 0.03 to 0.06 mg per kilogram of body weight, two or three times a day to 320 inpatients after bowel resection — the three arms of the dose-finding phase 2, none of them given under the skin. Route: intravenous.

What has and has not been tested for CJC-1295 and Ipamorelin

BPC-157 and TB-500 — 10 mg plus 10 mg

Fixed at 1 to 1. In 3 mL of water, one U-100 unit carries 33.3 mcg of BPC-157 and 33.3 mcg of TB-500.

Ask this vial for 250 mcg of BPC-157 and 1,000 mcg of TB-500:

Set by BPC-157, the draw is 7.5 units and it brings 250 mcg of TB-500 — less than the 1,000 asked for.

Set by TB-500 instead and the draw is 30.0 units, which brings 1,000 mcg of BPC-157.

No draw between them gives both. The vial is short of TB-500 for this pair of amounts.

BPC-157
Reported dose details

Reported use: 200 to 500 mcg a day, by injection under the skin or by mouth; the review says this came from animal data, not a human dosing study. This is not an established dose.

TB-500
No human dose listed

No published human dose is listed here.

What has and has not been tested for BPC-157 and TB-500

Tesamorelin and Ipamorelin — 10 mg plus 5 mg

Fixed at 2 to 1. In 3 mL of water, one U-100 unit carries 33.3 mcg of Tesamorelin and 16.7 mcg of Ipamorelin.

Ask this vial for 1,400 mcg of Tesamorelin and 300 mcg of Ipamorelin:

Set by Tesamorelin, the draw is 42.0 units and it brings 700 mcg of Ipamorelin — more than the 300 asked for.

Set by Ipamorelin instead and the draw is 18.0 units, which brings 600 mcg of Tesamorelin.

No draw between them gives both. The vial is short of Tesamorelin for this pair of amounts.

Tesamorelin
Approved product dose details

Approved product label: 1.4 mg once daily into the abdomen (Egrifta SV, the 2 mg-per-vial formulation). Route: subcutaneous.

Ipamorelin
Human study dose details

Human study: 0.03 to 0.06 mg per kilogram of body weight, two or three times a day to 320 inpatients after bowel resection — the three arms of the dose-finding phase 2, none of them given under the skin. Route: intravenous.

What has and has not been tested for Tesamorelin and Ipamorelin

What this tool does not tell you

The result depends on the vial amounts and liquid volume you enter. It cannot confirm what is in a vial, select a dose or establish whether a combination is suitable for you. The linked combination guides explain the evidence for each pair.